Nexalin Technology (NXL) Selling, General & Administrative (2021 - 2026)
Nexalin Technology (NXL) posted Selling, General & Administrative of $852,838 for Q2 2026, down 4.6% from $893,836 a year earlier but up 6.4% from the prior quarter.
Powered by 
Analysis
Nexalin Technology (NXL) Selling, General & Administrative (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Nexalin Technology was $4.23 million, down 14.9% year-over-year; for FY2025, it came in at $4.4 million, up 4.0% from FY2024.
- Annual Selling, General & Administrative has increased for three consecutive years, though with a four-year compound annual growth rate of -4.2% (FY2021 to FY2025).
- In prior years, Nexalin Technology's Selling, General & Administrative was $4.23 million in FY2024 (+78.6%), $2.37 million in FY2023 (+58.7%), $1.49 million in FY2022 (-71.4%) and $5.22 million in FY2021.
- Quarterly Selling, General & Administrative has run from a low of -$401,820 in Q4 2023 to a high of $1.95 million in Q3 2023 over five years.
- On a year-over-year basis, Selling, General & Administrative has declined in each of the last four quarters, with growth averaging 4.6% over the last seven quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2023, with growth of 305.7%; the weakest was Q3 2022, with a decline of 70.4%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $801,904 (Q1 2026), $1.16 million (Q4 2025) and $1.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 2.33 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 4.03 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 2.07 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 617.90 Mn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 3.20 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 2.23 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 1.80 Bn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 561.20 Mn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 1.26 Bn |
| 10 | Nexalin Technology | 4.20 Mn | -7.59 Mn | 8,897.00 | 852,838.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 852,838.00 |
| Mar 31, 2026 | 801,904.00 |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.42 Mn |
| Jun 30, 2025 | 893,836.00 |
| Mar 31, 2025 | 929,220.00 |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 598,757.00 |
| Mar 31, 2024 | 645,719.00 |
| Dec 31, 2023 | -401,820.00 |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 479,545.00 |
| Mar 31, 2023 | 344,953.00 |
| Dec 31, 2022 | 407,930.00 |
| Sep 30, 2022 | 479,445.00 |
| Jun 30, 2022 | 385,990.00 |
| Mar 31, 2022 | 218,374.00 |
| Dec 31, 2021 | 296,093.00 |
| Sep 30, 2021 | 1.62 Mn |
API Access
Nexalin Technology Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();